High Survivin Expression as a Risk Factor in Patients With Anal Carcinoma Treated With Concurrent Chemoradiotherapy
Radiation Oncology - United Kingdom
doi 10.1186/1748-717x-7-88
Full Text
Open PDFAbstract
Available in full text
Date
June 14, 2012
Authors
Publisher
Springer Science and Business Media LLC